This study discovered a novel small-molecule compound (IMCA) for CRC treatment in vitro and in vivo, and elucidated that IMCA induces ferroptosis by downregulating SLC7A11 expression through the AMPK/mTOR pathway. The gene discussed is MTOR; the disease is colorectal carcinoma.